SCHEMBL23179397

SCHEMBL23179397

c1ccc(-c2ccccc2-c2cccc(N(c3ccc(-c4cccc(-c5ccc6ccccc6c5)c4)cc3)c3ccc(-c4ccc5c(c4)oc4ccccc45)cc3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.38
▸ HSD17B1 P14061 2/20 0.36
▸ HSD17B2 P37059 2/20 0.36
▸ MMP12 P39900 1/20 0.35
▸ MMP13 P45452 1/20 0.35
▸ PLA2G2A P14555 3/20 0.35
▸ PLA2G4A P47712 3/20 0.35
▸ ALOX5 P09917 1/20 0.34
▸ ANO1 Q5XXA6 1/20 0.33
▸ PLA2G10 O15496 1/20 0.33
▸ PRKDC P78527 2/20 0.33
▸ GPR84 Q9NQS5 1/20 0.33
▸ PGR P06401 1/20 0.33
▸ AHR P35869 1/20 0.33
▸ ALDH1A1 P00352 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ CYP1A1 P04798 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP1B1 Q16678 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23180843 1.00 HCRTR1 (0.38) HCRTR1HSD17B1HSD17B2MMP12MMP13
SCHEMBL23179249 0.98 HCRTR1 (0.36) HCRTR1HSD17B1HSD17B2MMP12MMP13
SCHEMBL24841788 0.98 HCRTR1 (0.36) HCRTR1HSD17B1HSD17B2MMP12MMP13
SCHEMBL24841610 0.96 HCRTR1 (0.39) HCRTR1HSD17B1HSD17B2MMP12MMP13
SCHEMBL23180171 0.96 HCRTR1 (0.39) HCRTR1HSD17B1HSD17B2MMP12MMP13
SCHEMBL23180207 0.95 HCRTR1 (0.38) HCRTR1HSD17B1HSD17B2MMP12MMP13
SCHEMBL24841345 0.94 PLA2G2A (0.37) HCRTR1HSD17B1HSD17B2MMP12MMP13
SCHEMBL23180788 0.94 PLA2G2A (0.37) HCRTR1HSD17B1HSD17B2MMP12MMP13
SCHEMBL24919458 0.94 HCRTR1 (0.42) HCRTR1HSD17B1HSD17B2MMP12MMP13
SCHEMBL23180882 0.94 HCRTR1 (0.42) HCRTR1HSD17B1HSD17B2MMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230006136-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-05 — — US disclosed
WO-2021060239-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE 出光興産株式会社 2021-04-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230006136-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, POU2F1 HCRTR1 3540/4885HSD17B1 2198/4885HSD17B2 2307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback